Prevalence, Glycemic Efficacy, and Safety of Four Non-Insulin Antidiabetic Drug Combinations in Patients with Type 2 Diabetes

20260 citationsJournal Article

Authors

Georgios S. Papaetis · Paphos General Hospital

Gregory M. Dwyer · Cyprus University of Technology

Andriana M. Till · Cyprus University of Technology

Anastasia Papapostolou · Alion Science and Technology (United States)

Michalis K. Picolos · Alion Science and Technology (United States)

Abstract

In this study, 13.7% of patients with T2D received quadruple non-insulin drug combinations. Larger randomized controlled trials are needed to further evaluate their safety, efficacy, limitations, and potential role in T2D management.

Topics & Keywords

Diabetes Treatment and Management Diabetes, Cardiovascular Risks, and Lipoproteins Diabetes Management and Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Endocrine Metabolic & Immune Disorders - Drug Targets

Volume 26

DOI: 10.2174/0118715303402479251129144029

Field-Weighted Citation Impact: 0.00